Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target

Published:2018-12-12 Issue:1 Volume:10 Page:190-200
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Ye Na¹²,Li Bang¹,Mao Qi¹,Wold Eric A.²^ORCID,Tian Sheng¹,Allen John A.²,Zhou Jia²^ORCID

Affiliation:

1. Department of Medicinal Chemistry, Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China

2. Department of Pharmacology and Toxicology, Center for Addiction Research, University of Texas Medical Branch, Galveston, Texas 77555, United States

Funder

National Institute on Drug Abuse

National Natural Science Foundation of China

Pharmaceutical Research and Manufacturers of America Foundation

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00572

Reference82 articles.

1. Strategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors

2. Diversity and modularity of G protein-coupled receptor structures

3. Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets

4. How Ligands Illuminate GPCR Molecular Pharmacology

5. Trends in the exploitation of novel drug targets

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent changes in nociceptor translatomes govern hyperalgesic priming in mouse models;2024-08-08

2. Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for In Vivo Mouse Studies;Journal of Medicinal Chemistry;2024-07-01

3. Exploring orphan GPCRs in neurodegenerative diseases;Frontiers in Pharmacology;2024-06-04

4. Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists;Journal of Medicinal Chemistry;2024-05-24

5. Patent highlights August–September 2023;Pharmaceutical Patent Analyst;2024-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3